Janssen-Cilag Limited
Supplier
The register writes this name in capitals: JANSSEN-CILAG LIMITED.
- Sector
- Companies
- Agreements as applicant
- 1
- In term in September 2026
- 0
- Distinct datasets
- 4
- Files released
- 0
- Latest agreement end date
- 31 March 2021
Files released counts only files released externally by DARS. Access granted in NHS England's own systems, such as its Secure Data Environment, is not included.
Agreements
| Agreement | Datasets | Files | Latest term | Status | Commercial |
|---|---|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older DARS-NIC-409280-J6T3M | 1 | 0 | 16 November 2020 to 31 March 2021 | Expired | Yes |
Also listed as a data controller
Agreements where Janssen-Cilag Limited is named as a data controller rather than the applicant. This is matched from the free-text controller field on each agreement, so a controller recorded under a different spelling of the name won't appear here.
| Agreement | Applicant | Latest term | Status |
|---|---|---|---|
| Pulmonary Hypertension (PH) population characterisation and epidemiological analysis DARS-NIC-296034-T4Y4K | IQVIA Ltd | 21 June 2023 to 18 May 2024 | Expired |
Datasets named in its agreements
- Hospital Episode Statistics Accident and Emergency (HES A and E)
- Hospital Episode Statistics Admitted Patient Care (HES APC)
- Hospital Episode Statistics Outpatients (HES OP)
- Permission to Contact
Cite this page
NHS England (2026) Data Uses Register, September 2026 edition, agreements naming Janssen-Cilag Limited. Read via NHS Data Access Explorer (unofficial), https://healthdatauses.uk/organisations/janssen-cilag-limited/ (accessed [date]).
This address stays the same, but the page is rebuilt with each monthly edition, so the citation names the edition it shows. Every edition's data is kept in the facts store.